Oxetacaine + Aluminum Hydroxide + Magnesium Hydroxide Suspension
Oxetacaine IP, Aluminium Hydroxide IP and Magnesium Hydroxide IP Oral Suspension · Antacids, Gastroenterology
SUSPENSION PRESENTATION:
Product Profile
Oxetacaine + Aluminum Hydroxide + Magnesium Hydroxide Oral Suspension is a clinically established, dual-action antacid and local anesthetic formulation — combining rapid acid neutralization with potent mucosal anesthesia for comprehensive relief from gastritis, peptic ulcer pain, and acid-related gastrointestinal discomfort. As a WHO-GMP certified pharmaceutical manufacturer in Baddi, Saar Biotech manufactures this Oxetacaine 10mg + Aluminum Hydroxide 291mg + Magnesium Hydroxide 98mg Suspension for pharmaceutical companies seeking third-party manufacturing, contract manufacturing, and private-label gastroenterology brand supply.
DCGI Approved
Comprehensive documentation and CDSCO support for rapid market entry in India.
Fast Turnaround
30-45 days lead time for new batches with state-of-the-art logistics.
Pan-India Supply & Contract Manufacturing
Description & Therapeutic Class
Oxetacaine + Aluminum Hydroxide + Magnesium Hydroxide Suspension belongs to the Suspensions category within the Antacids and Gastroenterology therapeutic segments. The clinical logic of this three-molecule combination is comprehensive:
- Oxetacaine 10 mg — a potent local anesthetic that provides symptomatic relief of pain associated with peptic ulcer and other acid-related conditions
- Aluminum Hydroxide 291 mg — a slow-acting antacid that provides sustained acid neutralization and mucosal protection
- Magnesium Hydroxide 98 mg — a fast-acting antacid that neutralizes stomach acid quickly
For pharmaceutical marketing companies, this product is a high-prescription gastroenterology SKU with consistent year-round demand. Saar Biotech manufactures it from our facility in Baddi with validated three-active suspension quality control and complete 170ml and 200ml packaging options.
Pan-India Supply & Contract Manufacturing
The Saar Biotech Advantage
At Saar Biotech, we manufacture this suspension using a controlled oral suspension manufacturing process that ensures dose uniformity, palatability, and packaging reliability.
Three-API Suspension Uniformity: Each active must be uniformly distributed. Our high-shear mixing and validated fill procedures ensure dose-to-dose consistency.
Taste Masking: We develop mint-flavoured suspension bases that mask the chalky taste of the antacid components and the bitterness of Oxetacaine.
pH and Stability Management: All three actives must remain chemically stable for 24 months under tropical storage conditions.
170ml and 200ml Pack Coverage: From dark amber bottles to measuring caps — Saar Biotech’s packaging options help gastroenterology brands stand out.
Pan-India Supply & Contract Manufacturing
Key Indications & Clinical Use
This suspension is manufactured and supplied by Saar Biotech for the following established clinical indications:
- Gastritis: Rapid and effective relief from gastric inflammation
- Esophagitis: Relief from esophageal mucosal irritation and pain
- Peptic Ulcer: Symptomatic relief of pain associated with peptic ulcer
- Heartburn of Pregnancy: Safe and effective relief during pregnancy
- Hiatus Hernia: Relief from acid reflux symptoms
Pan-India Supply & Contract Manufacturing
Mechanism of Action & Manufacturing Integrity
Three-Component Clinical Mechanism
Oxetacaine is a potent local anesthetic that acts on the gastric mucosa, providing symptomatic relief of pain associated with peptic ulcer and other acid-related conditions.
Aluminum Hydroxide is a slow-acting antacid that provides sustained acid neutralization and helps protect the stomach lining.
Magnesium Hydroxide is a fast-acting antacid that neutralizes stomach acid quickly, providing rapid relief from burning sensations.
Manufacturing Integrity
- Three-API Suspension Uniformity: Each active must be uniformly distributed. Our formulation team selects suspending agents that maintain uniform dispersion.
- pH and Stability Management: The suspension vehicle must remain chemically stable for 24 months under tropical storage conditions.
Pan-India Supply & Contract Manufacturing
B2B & Contract Manufacturing Details
Saar Biotech provides Third-Party Manufacturing and Contract Manufacturing for this suspension from our dedicated oral suspension manufacturing facility in Baddi, Himachal Pradesh.
- Facility: Oral liquid and suspension manufacturing area with controlled processing, automated bottle filling, capping, labelling, and carton packing lines.
- Capacity: Scalable from brand-entry launches to large commercial batches.
- Quality Lab: In-house GLP-certified lab with validated assay for all three actives.
- Turnaround: New orders — 30 to 45 working days. Repeat orders — 20 to 25 working days.
- Packaging: 170ml and 200ml PET or dark amber bottles; sticker label, metallic label, measuring cup, printed cap.
- MOQ: Starting at 5,000–10,000 units per SKU.
Pan-India Supply & Contract Manufacturing
Storage & Handling Guidelines
- Warehouse Conditions: Store below 30°C in a cool, dry environment. Do not freeze.
- Shake Well Before Every Dose: This is the single most important user instruction for a suspension product.
- Measuring Cup Use: A calibrated measuring cup must accompany the bottle.
- Light Protection: Dark amber bottles and outer cartons protect the suspension from light-induced degradation.
Pan-India Supply & Contract Manufacturing
Quality Control & Compliance
Every commercial batch is quarantined until it passes a comprehensive analytical release protocol:
- Three-API Assay: HPLC for Oxetacaine, titrimetric for Aluminum and Magnesium Hydroxides.
- Suspension Uniformity & Re-Dispersibility: Sediment behaviour and post-shaking uniformity are evaluated.
- pH & Viscosity Testing: The suspension vehicle’s pH and flow characteristics are monitored.
- Microbial Limit Testing (MLT): IP-compliant microbiological testing.
- Certificate of Analysis (COA): Issued with every B2B batch.
Pan-India Supply & Contract Manufacturing
Safety Profile & Precautions
- Constipation Risk (Aluminum Hydroxide): May cause constipation, particularly with prolonged use.
- Bowel Hypomotility (Magnesium): Large doses may cause hypomotility of the bowel.
- Renal Precautions: In patients with renal impairment, plasma levels of both aluminum and magnesium may increase.
- Phosphate Depletion: Long-term use in patients with low-phosphorous diets may lead to phosphate depletion.
For third-party manufacturing enquiries, private-label contracts, or to request pricing and packaging options for Oxetacaine + Aluminum Hydroxide + Magnesium Hydroxide Suspension, please use the B2B enquiry form below.
Pan-India Supply & Contract Manufacturing
Clinical Q&A for Oxetacaine + Aluminum Hydroxide + Magnesium Hydroxide Suspension
Technical data on bioavailability, pediatric dosing protocols, and therapeutic efficacy for healthcare professionals.
What are the clinical indications for Oxetacaine + Aluminum Hydroxide + Magnesium Hydroxide Suspension?
How does this three-component combination work?
What is the standard dosing protocol?
What are the key contraindications and precautions?
What drug interactions should be considered?
B2B Manufacturing Guide for Oxetacaine + Aluminum Hydroxide + Magnesium Hydroxide Suspension
Detailed insights on MOQs, lead times, and regulatory support for contractmanufacturing partners.
